Clinical Development

SGS completes Ph I trial of new influenza virus

The First-in-Human trial demonstrated that the novel challenge agent had high attack rates of up to 100%. (Image: iStock/bodym)

SGS has completed a Phase I clinical trial of a new influenza virus strain in healthy volunteers and has increased capacity at its Mississauga, Canada-based laboratory.

iStock/olm26250

EMA proposal concerns: “Public health trumps commercial confidentiality”

(Image: iStock/DigtialStorm)

Acurian: new consulting service provides 'continuum of support'

(Image: PPD)

PPD ups capacity at vaccine development lab

(Image: iStock/Pinkypills)

Eli Lilly taps Cogstate as preferred provider

(Image: iStock/sudok1)

LabCorp completes acquisition of PAML

(Image: iStock/nito100)

Concise without compromise: clinical trial consent forms need reader-friendly revamp

iStock/Esperanza33

AB Science suspends French masitinib trials after ANSM finds deviations

(Image: iStock/klenger)

RBM provider expands in US Northeast to support CRO, sponsor demand

AG Mednet is an electronic data collection and submission service provider. (Image: iStock/MickeyCZ)

AG Mednet launches Judi to help sponsors, CROs manage clinical events

More Clinical Development